Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Complications of atherosclerosis are the most common cause of death in Western societies. Among the many risk factors identified by epidemiological studies, only elevated levels of lipoproteins containing apolipoprotein (apo) B can drive the development of atherosclerosis in humans and experimental animals even in the absence of other risk factors. However, the mechanisms that lead to atherosclerosis are still poorly understood. We tested the hypothesis that the subendothelial retention of atherogenic apoB-containing lipoproteins is the initiating event in atherogenesis. The extracellular matrix of the subendothelium, particularly proteoglycans, is thought to play a major role in the retention of atherogenic lipoproteins. The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycans. Here we present direct experimental evidence that the atherogenicity of apoB-containing low-density lipoproteins (LDL) is linked to their affinity for artery wall proteoglycans. Mice expressing proteoglycan-binding-defective LDL developed significantly less atherosclerosis than mice expressing wild-type control LDL. We conclude that subendothelial retention of apoB100-containing lipoprotein is an early step in atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated concentration of low-density lipoprotein enhances its retention under the arterial wall(17); retention and oxidation of low-density lipoprotein are fundamental events in atherogenesis.(18)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [18]
In the citing paper
“The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans (particularly chondroitin sulphate of biglycan and versican and heparin sulphate of perlecan 110 ) with positively charged apolipoproteins (especially apolipoprotein B) , which leads to the retention of plasma-derived lipoproteins 101,111 - as”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [101]
In the citing paper
“the interaction of apoB-containing lipoproteins (the non-HDL lipoproteins) with intimal extracellular proteoglycans (referred to as retention)1,43,44 inhibits the movement of the lipoproteins, thereby resulting in much higher subendothelial concentrations of these lipoproteins in the intima than in any other tissue45.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [44]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
A simple fluorometric assay for lipoperoxide in blood plasma
Yagi, K. (1976) · Biochemical Medicine · doi:10.1016/0006-2944(76)90049-1 · Cited by 2,103 · cited 1×
“The concentrations of thiobarbituric-acid-reactive substance”
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003 · cited 1×
“gif" NDATA ITEM> ]> Complications of atherosclerosis are the most common cause of death in Western societie”
BackgroundTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Self-citationBorén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · cited 1×
“The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycan”
BackgroundSelf-citationImmunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti, A., Kaveri, S., Caligiuri, G., Bariéty, J., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119892 · Cited by 301
Cited by
Items 401–500 of 1,000
Hashimura, K., Sudhir, K., Nigro, J., Ling, S., Williams, M. R. I., Komesaroff, P. A., & Little, P. J. (2005) · Endocrinology · doi:10.1210/en.2004-1242 · Cited by 33
Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans
Tannock, L. R., Little, P. J., Tsoi, C., Barrett, P. H. R., Wight, T. N., & Chait, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1358-y · Cited by 30
“At equal cholesterol levels, the mice expressing proteoglycan-binding-defective apolipoprotein B100 had significantly less atherosclerosis [16].”
BackgroundAraujo, G., Valencia, L. M., Martin-Ozimek, A., Soto, Y., & Proctor, S. D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1485801 · Cited by 34
Pillai, S. C., Borah, A., Jacob, E. M., & Kumar, D. S. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1892241 · Cited by 33
“Low-density lipoprotein (LDL), one of the most important atherogenic lipoproteins delivers cholesterol (Musunuru & Kathiresan, 2016) to the peripheral tissues (Skål en et al., 2002) which are linked to increased risk of CVD (The Emerging Risk Factors Collaboration, 2009).”
BackgroundRyoo, J., & Park, S. K. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.024 · Cited by 31
“Oxidation of ApoB creates proinflammatory products, which multiply and propagate atherogenesis within the arterial wall [24].”
BackgroundAntisense oligonucleotides as therapeutics for hyperlipidaemias
Crooke, R. M. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.7.907 · Cited by 29
“Due to the excellent correlation between elevated LDL-C plasma levels and the atherogenic process, its reduction has been the principal goal for CHD treatment and prevention [2,6,7,9-16].”
BackgroundThe double‐edged sword of fibronectin in atherosclerosis
Moore, K. J., & Fisher, E. A. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200238 · Cited by 30
“…the apoB100 molecule on the LDL particle has a specific domain that binds tightly to the ECM, and genetic causation studies in a mouse model of atherosclerosis have shown that when this domain is deleted, plaque burden is significantly reduced despite equivalent hyperlipidemia (Skalen et al, 2002).”
Dunér, P., To, F., Alm, R., Gonçalves, I., Fredrikson, G. N., Hedblad, B., Berglund, G., Nilsson, J., & Bengtsson, E. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02067.x · Cited by 31
Causal Effect of Lipids and Lipoproteins on Atherosclerosis
Ference, B. A. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.001 · Cited by 28
Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall
Öörni, K., Lehti, S., Sjövall, P., & Kovanen, P. T. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530094819 · Cited by 38
Falco, L., Tessitore, V., Ciccarelli, G., D’Aquino, M. M. C., D’Andrea, A., Imbalzano, E., Golino, P., & Russo, V. (2023) · Antioxidants · doi:10.3390/antiox12061185 · Cited by 34
“The storage of low-density lipoproteins (LDL) in the intima is strongly related to the development of the fatty streak [59], which is the first morphological alteration that occurs in atherosclerosis [60].”
BackgroundYang, L., Luo, X., Hua, Z., Xue, X., Wang, X., Pang, M., Wang, T., Lü, A., & Liu, Y. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.86475 · Cited by 31
“Skålén et al. 123 created heterogeneous transgenic mice expressing recombinant LDL with a mutation in Apo B100, containing tyrosine replaced tryptophan-4369, basic amino acids in Apo B100 binding site (residues 3359-3369) changed to neutral amino acids, lysine 3363 in Apo B100 converted to glutamic acid and 6-GAGs bin…”
Staels, B. (2002) · Nature · doi:10.1038/417699a · Cited by 31
Yaosheng, W., Zhou, Y., He, L., Hong, K., Su, H., Wu, Y., Wu, Q., Han, M., & Cheng, X. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0112-7 · Cited by 28
Comparative Endocrinology of Aging and Longevity Regulation
Allard, J. B., & Duan, C. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00075 · Cited by 32
“LDL particles are actively transported through the endothelial cell layer to the subendothelial matrix (Vasile et al., 1983; Ishibashi et al., 1994) where they bind to negatively charged proteoglycan molecules, and accumulate (Skalen et al., 2002; Tabas et al., 2007; Nakashima et al., 2008).”
BackgroundXiaolong, G., He, H., Lin, L., Luo, G., Wen, Y., Xiang, D., & Qiu, J. (2017) · Apmis · doi:10.1111/apm.12729 · Cited by 32
Nanomaterials to Resolve Atherosclerosis
Peters, E. B., & Kibbe, M. R. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00281 · Cited by 28
Edwards, I. J., Wagner, J. D., Vogl-Willis, C. A., Litwak, K. N., & Cefalu, W. T. (2004) · Cardiovascular Diabetology · doi:10.1186/1475-2840-3-6 · Cited by 32
Nagy, N., Melchior‐Becker, A., & Fischer, J. W. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0051-1 · Cited by 32
“This property places biglycan at the center of the ‘‘response-to-retention’’ hypothesis of atherogenesis assuming that increased biglycan expression in the arterial wall causes LDL retention in the ECM, facilitates LDL-modification and therefore initiates and accelerates the early events in the pathophysiology of athe…”
BackgroundAntibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice
Dunér, P., Mattisson, I. Y., Fogelstrand, P., Glise, L., Ruiz, S., Farina, C., Borén, J., Nilsson, J. Å., & Bengtsson, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-88430-1 · Cited by 27
Self-citationSanctis, S. D., Marcovecchio, M. L., Gaspari, S., Torto, M. D., Mohn, A., Chiarelli, F., & Breda, L. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121281 · Cited by 27
Adhikari, N., Basi, D. L., Townsend, D., Rusch, M. A., Mariash, A., Mullegama, S. V., Watson, A. L., Larson, J. D., Tan, S. S., Lerman, B., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.02.022 · Cited by 27
“The pathobiology of diseases including atherosclerosis and diabetes has been associated with alterations in heparan sulfate proteoglycans [26–28].”
REDD2 Gene Is Upregulated by Modified LDL or Hypoxia and Mediates Human Macrophage Cell Death
Cuaz‐Pérolin, C., Furman, C., Larigauderie, G., Legedz, L., Lasselin, C., Copin, C., Jaye, M., Searfoss, G. H., Yu, K. T., Duverger, N., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000142366.69080.c3 · Cited by 29
Twickler, T. B., Cramer, M. J., Dallinga‐Thie, G. M., Chapman, M. J., Erkelens, D. W., & Koppeschaar, H. P. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030278 · Cited by 28
Polydopamine-assisted deposition of heparin for selective adsorption of low-density lipoprotein
Liu, Y., Qiu, W., Yang, H., Qian, Y., Huang, X., & Xu, Z. (2015) · RSC Advances · doi:10.1039/c4ra16700g · Cited by 28
[Role of inflammation in atherogenesis].
Rodríguez, G., Mago, N., & Rosa, F. (2009) · Investigación Clínica · Cited by 38
Meyers, C. D., Tannock, L. R., Wight, T. N., & Chait, A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300252-jlr200 · Cited by 28
Lu, M., Gantz, D., Herscovitz, H., & Gursky, O. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m029629 · Cited by 27
Dose-Response Associations of Lipid Traits With Coronary Artery Disease and Mortality
Yang, G., Mason, A. M., Wood, A., Schooling, C. M., & Burgess, S. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.52572 · Cited by 31
Natural flavone tricetin suppresses oxidized LDL-induced endothelial inflammation mediated by Egr-1
Cai, L., Zhang, X., Hou, M., & Gao, F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106224 · Cited by 26
Seike, M., Ikeda, M., Matsumoto, M., Hamada, R., Takeya, M., & Kodama, H. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.10.008 · Cited by 26
“The response to retention theory indicates that the subendothelial retention of atherogenic apoB-containing lipoproteins is the initial event in atherogenesis [25].”
BackgroundPlihtari, R., Hurt-Camejo, E., Öörni, K., & Kovanen, P. T. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003103 · Cited by 25
Chen, X., Sun, A., Zou, Y., Ge, J., Lazar, J., & Jiang, X. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-25 · Cited by 31
“It is also known that non-HDL lipoprotein subendothelial retention is an early step in atherogenesis [30].”
BackgroundTannock, L. R., Kirk, E. A., King, V. L., LeBoeuf, R. C., Wight, T. N., & Chait, A. (2006) · Journal of Nutrition · doi:10.1093/jn/136.11.2856 · Cited by 25
“Proteoglycans in the artery wall play a key role in the development of atherosclerosis due to their ability to bind and retain atherogenic lipoproteins in the arterial wall (18).”
BackgroundCheng, F., Twardowski, L., Fehr, S., Aner, C., Schaeffeler, E., Joos, T. O., Knorpp, T., Dorweiler, B., Laufer, S., Schwab, M. G., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600669r · Cited by 25
Autophagy: a killer or guardian of vascular smooth muscle cells
Zhang, Y.-Y., Shi, Y.-N., Zhu, N., Wang, W., Deng, C.-F., Xie, X.-J., Liao, D.-F., & Qin, L. (2020) · Journal of Drug Targeting · doi:10.1080/1061186x.2019.1705312 · Cited by 24
“VSMCs are the most important source of extracellular matrix and atherosclerotic plaque, which is the main cause of pathological intimal thickening of early atherosclerosis [13,14].”
BackgroundElías-López, D., Vedel‐Krogh, S., Kobylecki, C. J., Wadström, B. N., & Nordestgaard, B. G. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321387 · Cited by 26
“20 The positive apoB sequences in human VLDL also contribute to the binding of the VLDL particles to the extracellular human arterial proteoglycans.”
Incremento de las HDL como arma terapéutica en la aterotrombosis
Badimón, J. J., & Ibáñez, B. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70091-9 · Cited by 34
She, Z., Chang, Y., Pang, H.-B., Han, W., Chen, H., Smith, J. W., & Stallcup, W. B. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306074 · Cited by 26
The Role of Age-Related Intimal Remodeling and Stiffening in Atherosclerosis
VanderBurgh, J. A., & Reinhart‐King, C. A. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.08.008 · Cited by 24
Guo, X., Liu, Y., Zheng, X., Han, Y., & Cheng, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117445 · Cited by 26
Radiation Impacts Early Atherosclerosis by Suppressing Intimal LDL Accumulation
Ikeda, J., Scipione, C. A., Hyduk, S. J., Althagafi, M. G., Atif, J., Dick, S. A., Rajora, M. A., Jang, E., Emoto, T., Murakami, J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.119.316539 · Cited by 28
The Initial Human Atherosclerotic Lesion and Lipoprotein Modification—A Deep Connection
Torzewski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111488 · Cited by 26
“Transgenic mice expressing modified apolipoprotein B that binds poorly to proteoglycans show reduced atheroma development [51].”
BackgroundDetection of Vascular Disease Risk in Women by Panoramic Radiography
Taguchi, A., Suei, Y., Sanada, M., Higashi, Y., Ohtsuka, M., Nakamoto, T., Tsuda, M., Ohama, K., & Tanimoto, K. (2003) · Journal of Dental Research · doi:10.1177/154405910308201015 · Cited by 24
“The mandibular cortical erosion category was significantly associated with low-density lipoprotein cholesterol level and apolipoprotein B level, both of which contribute to an early stage of atherogenesis (Skalen et al., 2002).”
BackgroundParadoxical Effects of Fenofibrate and Nicotinic Acid in Apo E-Deficient Mice
DeClercq, V., Yeganeh, B., Moshtaghi‐Kashanian, G., Khademi, H., Bahadori, B., & Moghadasian, M. H. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000162764.12309.25 · Cited by 24
“Atherosclerosis is a complex vascular disease initiated by abnormal accumulation of plasma lipoproteins in the subendothelial space of the blood vessels.(2) It is now well known that elevated plasma levels of atherogenic low-density lipoprotein (LDL) particles and decreased levels of antiatherogenic high-density lipop…”
BackgroundAtherosclerosis and the immune system
Hansson, G. K., & Paulsson‐Berne, G. (2004) · Acta Paediatrica · doi:10.1111/j.1651-2227.2004.tb00241.x · Cited by 27
“Extracellular accumulation of lipids occurs very early in response to increased plasma lipoprotein levels in animals (1, 2).”
BackgroundM1/M2 macrophage-targeted nanotechnology and PROTAC for the treatment of atherosclerosis
Ma, Y., Yang, X., Ning, K., & Guo, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122811 · Cited by 23
Jiang, D., Li, X., & Jia, Q. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201705280 · Cited by 23
Amaro, A. B., Pallara, C., Nasarre, L., Rivas-Urbina, A., Benítez, S., Vea, À., Bornachea, O., de Gonzalo‐Calvo, D., Serra-Mir, G., Villegas, S., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.05.003 · Cited by 28
Label-free analytic histology of carotid atherosclerosis by mid-infrared optoacoustic microscopy
Visscher, M., Pleitez, M. A., van Gaalen, K., Nieuwenhuizen‐Bakker, I., Ntziachristos, V., & van Soest, G. (2022) · Photoacoustics · doi:10.1016/j.pacs.2022.100354 · Cited by 23
“Initiated by the infiltration of low density lipoproteins (LDL) into the sub-endothelial layer [3], lipids play a major role in the development of atherosclerosis.”
BackgroundHuseynov, A., Reinhardt, J., Chandra, L., Dürschmied, D., & Langer, H. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076280 · Cited by 26
“Endocytosis of such particles from macrophages, derived from monocytes, results in an intracellular accumulation of cholesterol (Figure 1) [13] These monocytes then differentiate into tissue macrophages and remain in the plaque [14] According to current data, a central role in plaque formation is attributed to oxidize…”
BackgroundHDL and LDL have distinct, opposing effects on LPS-induced brain inflammation
Radford‐Smith, D. E., Yates, A. G., Rizvi, L., Anthony, D. C., & Probert, F. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01817-z · Cited by 27
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Sobenin, I. A., Chistiakov, D. A., Bobryshev, Y. V., Postnov, A. Y., & Orekhov, A. N. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319330014 · Cited by 23
“The key initiating process in atherogenesis is the subendothelial retention of apo B-containing lipoproteins [51].”
BackgroundFontana, L., Giagulli, C., Cominacini, L., Pasini, A. F., Minuz, P., Lechi, A., Sala, A., & Laudanna, C. (2002) · Circulation · doi:10.1161/01.cir.0000037223.92135.38 · Cited by 26
Therapeutic agents for the management of atherosclerosis from herbal sources
Kajal, A., Kishore, L., Kaur, N., Gollen, R., & Singh, R. (2016) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1016/j.bjbas.2016.02.004 · Cited by 28
Schnitzler, J. G., Dallinga‐Thie, G. M., & Kroon, J. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180316121015 · Cited by 29
Verseijden, C., Meijssen, S., & Cabezas, M. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032171 · Cited by 25
“Marginated lipoproteins most likely are bound to the endothelium by LPL-phospholipid interactions or by means of receptor-ligand interactions in different tissues and represent those lipoproteins that potentially are in the process of migrating into the subendothelial space (20).”
BackgroundInfluentialKralev, S., Zimmerer, E., Brueckmann, M., Lang, S., Kälsch, T., Rippert, A., Lin, J., Borggrefe, M. M., Hammes, H., & Süselbeck, T. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.100 · Cited by 23
Nuevas técnicas de imagen para la cuantificación de la carga aterosclerótica global
Ibáñez, B., Pinero, A., Orejas, M., & Badimón, J. J. (2007) · Revista Española de Cardiología · doi:10.1157/13100282 · Cited by 29
The Role of Interleukin-18 in the Development and Progression of Atherosclerosis
Bahrami, A., Sathyapalan, T., & Sahebkar, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200427095830 · Cited by 26
“[6] Skålén K, Gustafsson M, Rydberg EK, Hultén LM, Wiklund O, Innerarity TL, Borén J.”
BackgroundMDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses
Martos-Folgado, I., Monte-Monge, A. D., Lorenzo, C., Busse, C. E., Delgado, P., Mur, S. M., Cobos-Figueroa, L., Escolá‐Gil, J. C., Martín-Ventura, J. L., Wardemann, H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111468 · Cited by 27
Jia, X., Liu, Z., Wang, Y., Li, G., & Bai, X. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.03.004 · Cited by 22
The role of fibromodulin in inflammatory responses and diseases associated with inflammation
Zhao, F., Bai, Y., Xiang, X., & Pang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1191787 · Cited by 27
Lhoëst, M. T. L. C., Martinez, A., Claudi, L., Garcia, E., Amaro, A. B., Polishchuk, A., Piñero, J., Viladés, D., Palmero, M. J. G., Sanz, F., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1381520 · Cited by 25
“Blocking this interaction by saturating the GAG chain binding sites with small peptide mimetics successfully prevents atherosclerosis in a mouse model (93).”
Shanmuganayagam, D., Beahm, M. R., Kuhns, M. A., Krueger, C. G., Reed, J. D., & Folts, J. D. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf203487g · Cited by 26
LDL aggregation susceptibility is higher in healthy South Asian compared with white Caucasian men
Ruuth, M. K., Janssen, L. G. M., Äikäs, L., Tigistu‐Sahle, F., Nahon, K. J., Ritvos, O., Ruhanen, H., Käkelä, R., Boon, M. R., Öörni, K., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.09.011 · Cited by 23
Guha, M., England, C., Herscovitz, H., & Gursky, O. (2007) · Biochemistry · doi:10.1021/bi7001532 · Cited by 22
Yagi, K., Hifumi, S., Nohara, A., Higashikata, T., Inazu, A., Mizuno, K.-O., Namura, M., Ueda, K., Kobayashi, J., Shimizu, M., et al. (2004) · Circulation Journal · doi:10.1253/circj.68.623 · Cited by 24
Glycans in Diseases and Therapeutics
Pavão, M. S. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-16833-8 · Cited by 24
Maaninka, K., Nguyen, S. D., Mäyränpää, M. I., Plihtari, R., Rajamäki, K., Lindsberg, P. J., Kovanen, P. T., & Öörni, K. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.04.016 · Cited by 21
Keyes, E., Grinnell, M., Jacoby, D. S., Vazquez, T., Diaz, D., Werth, V. P., & Williams, K. J. (2021) · International Journal of Women’s Dermatology · doi:10.1016/j.ijwd.2021.08.015 · Cited by 21
Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge
Donisan, T., Madanat, L., Balanescu, D. V., Mertens, A. N., & Dixon, S. R. (2023) · Current Cardiology Reviews · doi:10.2174/1573403x19666230103154638 · Cited by 25
“Endothelial activation leads to increased cell permeability, leading to higher lipoprotein concentrations in the subendothelial space [48].”
BackgroundTwo decades of vaccine development against atherosclerosis
Moreno‐Gonzalez, M. A., Ortega-Rivera, O. A., & Steinmetz, N. F. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101822 · Cited by 22
Shewale, S. V., Boudyguina, E. Y., Zhu, X., Shen, L., Hutchins, P. M., Barkley, R. M., Murphy, R. C., & Parks, J. S. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m059170 · Cited by 23
Protein profiling of low‐density lipoprotein from obese subjects
Karlsson, H., Mörtstedt, H., Lindqvist, H. M., Tagesson, C., & Lindahl, M. G. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800138 · Cited by 21
“For example, apo B-100 has been proposed to expose specific sites at the surface and so promote retained interaction with the arterial wall proteoglycans [5, 6]: this retained LDL seems to be more susceptible to oxidation and more prone to cause foam cell formation [7].”
BackgroundGlycans and Glycan-Binding Proteins in Atherosclerosis
Eckardt, V., Weber, C., & von Hundelshausen, P. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1692720 · Cited by 21
Survase, S., Ivey, M. E., Nigro, J., Osman, N., & Little, P. J. (2005) · PubMed Central · Cited by 23
D’Ulivo, L., Saint‐Guirons, J., Ingemarsson, B., & Riekkola, M. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-3371-y · Cited by 21
“arterial proteoglycans and interact with apoB-100 through its negatively charged sulfate groups [6, 7].”
BackgroundAtherin: a newly identified, lesion-specific, LDL-binding protein in human atherosclerosis
Lees, A. M., Deconinck, A. E., Campbell, B., & Lees, R. S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.041 · Cited by 22
The Role of Oxidative Stress in Endothelial Dysfunction and Vascular Inflammation
Osto, E., & Cosentino, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00022-8 · Cited by 28
Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease
Soto, Y., CONDE, H., Aportela, R. A., Brito, V., Lorenzo-Luaces, P., Nasiff, A., Obregón, A. L., & López, A. M. V. (2009) · Human Antibodies · doi:10.3233/hab-2009-0202 · Cited by 21
“Oxidized LDL (oxLDL) can be internalized by macrophages throughthe scavenger receptors on the surfaces of these cells, leading to the accumulation of intracellular cholesterol with the consequent formation of foam cells [4].”
Nakano, M., & Virmani, R. (2014) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-014-0281-5 · Cited by 20
“Proteoglycans are suggested to be a possible contributor to the promotion of atherosclerosis through ionic interaction between glycosaminoglycans and lipoproteins [17].”
BackgroundLightbody, R. J., Taylor, J. M. W., Dempsie, Y., & Graham, A. (2020) · World Journal of Cardiology · doi:10.4330/wjc.v12.i7.303 · Cited by 21
Smooth Muscle Cell-Proteoglycan-Lipoprotein Interactions as Drivers of Atherosclerosis
Allahverdian, S., Ortega, C., & Francis, G. A. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_364 · Cited by 32
Lebeau, P. F., Platko, K., Byun, J. H., Makda, Y., & Austin, R. C. (2022) · Metabolites · doi:10.3390/metabo12030215 · Cited by 20
Marzoll, A., Melchior‐Becker, A., Cipollone, F., & Fischer, J. W. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00986.x · Cited by 20
“The current results may also be of interest with respect to the response to retention hypothesis of atherosclerosis, which points out the contribution of proteoglycans including biglycan to early LDL retention [39].”
ResultGlycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells
Ballinger, M. L., Thomas, M. C., Nigro, J., Ivey, M. E., Dilley, R. J., & Little, P. J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00746.x · Cited by 20
“First, the lipid-dependent binding and retention of atherogenic lipoproteins by vascular extracellular matrix molecules, including proteoglycans [22, 29, 30]; second, the inflammatory process of monocyte adhesion to the vessel wall and subsequent macrophage proliferation [12, 31].”
BackgroundCross-Talk between Lipoproteins and Inflammation: The Role of Microvesicles
Chiva‐Blanch, G., & Badimón, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122059 · Cited by 21
“As previously mentioned and summarized in Figure 2, monocyte-derived macrophages accumulate cholesterol modified within the arterial wall during atherogenesis [54].”
BackgroundEckersley, A., Ozols, M., Chen, P., Tam, V., Ward, L. J., Hoyland, J. A., Trafford, A. W., Yuan, X., Schiller, H. B., Chan, D. T.-M., et al. (2022) · Matrix Biology · doi:10.1016/j.matbio.2022.05.007 · Cited by 19
New insights into macrophage subsets in atherosclerosis
Wang, Y., Wang, Q. A., & Xu, D. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02224-0 · Cited by 20
“The retention of infiltrating LDL particles on proteoglycans in the subendothelial space is an initiating event in the development of AS [4].”
BackgroundApoE gene therapy to treat hyperlipidemia and atherosclerosis.
Harris, J., Evans, & Owen, J. S. (2006) · PubMed · Cited by 27
Inflammatory and Autoimmune Reactions in Atherosclerosis and Vaccine Design Informatics
Jan, M., Meng, S., Chen, N. C., Mai, J., Wang, H., & Yang, X. (2010) · BioMed Research International · doi:10.1155/2010/459798 · Cited by 21
“Thus, macrophages are involved in both innate and adaptive immune responses during atherosclerosis.”
BackgroundTang, T., Wilson, P. G., Thompson, J. C., Nelson, C., Yoder, M. H., & Tannock, L. R. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p040139 · Cited by 21
Anti-Inflammatory Effects of Anti-Platelet Treatment in Atherosclerosis
Arazi, H. C., & Badimon, J. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802481264 · Cited by 19
Apolipoprotein B is a risk factor for end-stage renal disease
Kwon, S., Kim, D. K., Oh, K., Joo, K. W., Lim, C. S., Kim, Y. S., & Han, S. S. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfz186 · Cited by 23
“The ionic interaction between the negatively charged sulfate group on the extracellular matrix proteoglycans and the basic amino acids within ApoB promotes this deposition of lipid particles in the subendothelium [30].”
Backgroundvon Ballmoos, M. C. W., Dubler, D., Mirlacher, M., Cathomas, G., Muser, J., & Biedermann, B. C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000198250.91406.6d · Cited by 20
Zhang, Y., Li, F., Liu, L., An, Z., Luo, H., Zhang, H., Ma, R., Zhang, R., Dai, Q., Zhang, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202504990 · Cited by 25
Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing
Tep, S., Mihaila, R., Freeman, A., Pickering, V., Huynh, F. C., Tadin‐Strapps, M., Stracks, A., Hubbard, B. K., Caldwell, J. S., Flanagan, W. M., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m021063 · Cited by 19
Hagensen, M. K., Mortensen, M. B., Kjølby, M., Stillits, N. L., Steffensen, L. B., & Bentzon, J. F. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.05.019 · Cited by 19
Atherogenic Dyslipidemia After Liver Transplantation: Mechanisms and Clinical Implications
Syed, T., & Siddiqui, M. S. (2021) · Liver Transplantation · doi:10.1002/lt.26069 · Cited by 18
“1328 | Review ARticle formation.(19,20) In the endothelium, sdLDL particles are readily oxidized, which can promote inflammatory cascade, thereby leading to migration and differentiation of monocytes into macrophages.”
Background
Metadata
- Authors
- Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J.
- Affiliations
- University of Gothenburg (SE)
- Gladstone Institutes (US)
- Corresponding author
- Borén, Jan
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6890
- Pages
- 750-754
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083154566
- Cited by
- 1,019
- References
- 28
- Citations by year
- 2026: 23 · 2025: 28 · 2024: 38 · 2023: 42 · 2022: 41 · 2021: 69 · 2020: 48 · 2019: 39 · 2018: 39 · 2017: 29 · 2016: 27 · 2015: 46 · 2014: 42 · 2013: 42 · 2012: 63
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Heart Association
- Research to Prevent Blindness
- Vetenskapsrådet
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, atherogenesis, apolipoprotein B, apolipoprotein B-100, low-density lipoprotein, proteoglycans, extracellular matrix, sulfate groups, transgenic mice, atherogenic lipoproteins
- MeSH terms
- Animals, Aorta, Apolipoproteins B, Arteriosclerosis, Binding, Competitive, Cholesterol, Diet, Atherogenic, Endothelium, Vascular, Female, Humans, Lipoproteins, Lipoproteins, LDL, Macrophages, Mice, Transgenic, Models, Biological, Mutation, Receptors, LDL, Recombinant Proteins, Triglycerides, Tumor Necrosis Factor-alpha, Amino Acid Substitution, Mice, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.